Home » Newsletters » BioWorld

BioWorld

Nov. 15, 2001

View Archived Issues

Conference Roundup

Abgenix Purchases Hesed For $15.9M In Stock, Cash

CV Therapeutics Plans NDA Following Phase III Angina Trial

Two-Faced Prostratin Molecule Rescues HIV From Latency, But Kills Its Uninfected Target Cells

Panel Says Industry Position Strong, VC Outlook Favorable

Other News To Note

Amgen Gains FDA Approval To Market Kineret For RA